Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Cardiovascular effects of psychotropic drugs

July 11, 1997

Chugai reports sydnonimine derivatives for angina

July 11, 1997

CPC-111 moves toward pivotal trials for bypass surgery

July 10, 1997

Yamanouchi, Ferring collaborate on endothelin antagonists

July 10, 1997

New lactam compounds for sepsis and RA

July 10, 1997

Low-dose combination of ramipril and felodipine evaluated in SHR

July 9, 1997

Fixed-dose losartan/hydrochlorothiazide combination now available in U.K.

July 8, 1997

Potent, selective and orally active ETA antagonist from Zeneca

July 8, 1997

Agent for restenosis in preclinical development at CV Therapeutics

July 7, 1997

New cardiovascular agent in development at CV Therapeutics

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...